SCM

Superstring Capital Management Portfolio holdings

AUM $80.3M
This Quarter Return
+21.19%
1 Year Return
+68.23%
3 Year Return
5 Year Return
10 Year Return
AUM
$151M
AUM Growth
+$151M
Cap. Flow
+$8M
Cap. Flow %
5.29%
Top 10 Hldgs %
64.45%
Holding
47
New
17
Increased
12
Reduced
7
Closed
10
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ALLK
26
DELISTED
Allakos
ALLK
$1.55M 1.03%
+1,233,739
New +$1.55M
CTMX icon
27
CytomX Therapeutics
CTMX
$336M
$1.48M 0.98%
+679,403
New +$1.48M
ANNX icon
28
Annexon
ANNX
$226M
$1.12M 0.74%
+155,728
New +$1.12M
RNA icon
29
Avidity Biosciences
RNA
$5.99B
$945K 0.62%
+37,031
New +$945K
LYRA icon
30
Lyra Therapeutics
LYRA
$11.5M
$904K 0.6%
+145,284
New +$904K
INZY
31
DELISTED
Inozyme Pharma
INZY
$864K 0.57%
112,739
-11,205
-9% -$85.8K
AUPH icon
32
Aurinia Pharmaceuticals
AUPH
$1.58B
$494K 0.33%
+98,691
New +$494K
KALV icon
33
KalVista Pharmaceuticals
KALV
$678M
$380K 0.25%
+32,025
New +$380K
ALPN
34
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
$358K 0.24%
+9,038
New +$358K
SPRB
35
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
$346K 0.23%
440,225
+321,411
+271% +$253K
LSB
36
LakeShore Biopharma
LSB
$33M
$216K 0.14%
307,920
SY
37
So-Young International
SY
$381M
$199K 0.13%
182,742
-613,317
-77% -$669K
IMTX icon
38
Immatics
IMTX
$619M
-79,213
Closed -$834K
IMVT icon
39
Immunovant
IMVT
$2.56B
-203,592
Closed -$8.58M
KRYS icon
40
Krystal Biotech
KRYS
$4.27B
-16,086
Closed -$2M
LNTH icon
41
Lantheus
LNTH
$3.73B
-54,896
Closed -$3.4M
NBIX icon
42
Neurocrine Biosciences
NBIX
$13.8B
-29,346
Closed -$3.87M
PTGX icon
43
Protagonist Therapeutics
PTGX
$3.67B
-379,143
Closed -$8.69M
QTRX icon
44
Quanterix
QTRX
$211M
-71,760
Closed -$1.96M
SLRN
45
DELISTED
ACELYRIN
SLRN
-356,924
Closed -$2.66M
FUSN
46
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
-45,801
Closed -$440K
IMGN
47
DELISTED
Immunogen Inc
IMGN
-598,072
Closed -$17.7M